Mara Macdonald

Mara Macdonald is an Investor at Brandon Capital Partners based in Melbourne, Victoria, Australia. She previously served as an investment associate at the firm and holds a Bachelor of Commerce in Finance from the University of Melbourne. In her current capacity, she sources and evaluates early-stage life sciences ventures, contributing to a portfolio of over 50 companies and managing capital across vehicles like the Brandon BioCatalyst fund. Promoted to her current role in 2024, Macdonald has participated in significant funding rounds, including the 2023 Series B for healthcare technology company Harrison.ai. She also tracks broader sector trends, recently speaking on biotech funding at the AusMedtech 2025 conference and monitoring developments alongside industry leaders like CSL Limited. Her primary professional focus remains on identifying and funding biotechnology and medical technology innovations through strategic venture capital allocation.